首页> 外国专利> HYALURONIDASE INHIBITOR OR THERAPEUTIC AGENT OF ATOPIC DERMATITIS ORIGINATED FROM CLADOSIPHON OKAMURANUS TOKIDA

HYALURONIDASE INHIBITOR OR THERAPEUTIC AGENT OF ATOPIC DERMATITIS ORIGINATED FROM CLADOSIPHON OKAMURANUS TOKIDA

机译:冈比亚产的克拉多西根原发性皮肤炎的透明质酸酶抑制剂或治疗剂

摘要

PROBLEM TO BE SOLVED: To provide a hyaluronidase inhibitor or a therapeutic agent of atopic dermatitis, containing fucoidan obtained from an extract of seaweeds as an active ingredient, and utilizing the bioactivities thereof.;SOLUTION: The hyaluronidase inhibitor or the therapeutic agent of the atopic dermatitis contains the acetyl fucoidan obtained from Cladosiphon okamuranus TOKIDA or a sulfated product thereof as an active ingredient. The acetyl fucoidan is obtained by extracting the Cladosiphon okamuranus TOKIDA with a diluted aqueous hydrochloric acid solution or the like.;COPYRIGHT: (C)2008,JPO&INPIT
机译:解决的问题:提供透明质酸酶抑制剂或特应性皮炎的治疗剂,其含有从海藻提取物中获得的岩藻依聚糖作为活性成分,并利用其生物活性。解决方案:透明质酸酶抑制剂或特应性皮炎的治疗剂皮炎含有作为活性成分的,从冈田克拉多芬(Cladosiphon okamuranus TOKIDA)获得的乙酰基岩藻依聚糖或其硫酸化产物。乙酰基岩藻依聚糖是通过用稀盐酸水溶液等萃取克拉多芬(Cladosiphon okamuranus TOKIDA)获得的。版权所有:(C)2008,JPO&INPIT

著录项

  • 公开/公告号JP2008044913A

    专利类型

  • 公开/公告日2008-02-28

    原文格式PDF

  • 申请/专利权人 UNIV OF RYUKYUS;

    申请/专利号JP20060224007

  • 发明设计人 TOKESHI MINAMI;TAKO MASAKUNI;

    申请日2006-08-21

  • 分类号A61K31/737;A61P43/00;A61P37/08;A61P17/00;C12N9/99;A23L1/30;C08B37/00;A61K36/02;

  • 国家 JP

  • 入库时间 2022-08-21 20:21:42

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号